New method for reducing tumorigenicity in induced pluripotent stem-cell based therapies
The potential for clinical use of induced pluripotent stem cell (iPSC) technology for transplant-based therapeutic strategies has previously been hindered by the risk of dysregulated cell growth, specifically the development ...
Jul 23, 2014
0
0